Arjun Agarwal, Senior Vice President, Finance at Oruka Therapeutics, Inc. (ORKA), sold 10,290 shares at $58.34 ($608K) on 2026-05-18, disclosed to the SEC on 2026-05-18.
Scheduled sale ($608k) by Senior Vice President, Finance under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $58.34 | 4,190 | $244K | 40.2% |
| 2 | $59.19 | 4,600 | $272K | 44.8% |
| 3 | $60.34 | 800 | $48K | 7.9% |
| 4 | $61.16 | 700 | $43K | 7.0% |
| Total | $59.07 avg | 10,290 | $608K | 100% |
| Filing → |
| ORKA | SELL | 2026-09-15 | $926K | — | Filing → |
| ORKA | SELL | 2026-08-14 | $1.1M | — | Filing → |
| ORKA | SELL | 2026-07-13 | $846K | — | Filing → |